Corsano Health
  • Patient Care
    • General Wards
    • Remote Monitoring
    • Clinical Deterioration
    • Cardiac Arrest
  • Research
    • Clinical Trials
    • Pharma
    • eCOA
    • Education
  • System
    • CardioWatch 287
    • Vital Parameters
    • Data Access
    • System status
    • FAQ
  • Resources
    • Publications
    • Clinical Trials
    • White Papers
    • News
    • Insights
  • Company
    • About Us
    • Team
    • Careers
    • Compliance
    • Intranet
  • Support
  • Contact Us
Select Page
A machine learning model to detect falls mimicking cardiac arrest-related collapse based on wrist-derived accelerometry: the DETECT-2 study 

A machine learning model to detect falls mimicking cardiac arrest-related collapse based on wrist-derived accelerometry: the DETECT-2 study 

by Matthias Burel | Dec 20, 2021 | Publications

A machine learning model to detect falls mimicking cardiac arrest-related collapse based on wristderived accelerometry: the DETECT-2 study Roos Edgar, Kambiz Ebrahimkheil, Danny Meeuwsen, Maud C. de Jong,Job J. Herrmann, Alexander M. Griffioen, Niels T.B. Scholte,Marc...
Older patients successfully adopt CardioWatch during recovery after cancer surgery

Older patients successfully adopt CardioWatch during recovery after cancer surgery

by Matthias Burel | Dec 19, 2021 | Publications

Older patients successfully adopt CardioWatch during recovery after cancer surgery A qualitative study by Leiden University Medical Center evaluated the experiences of 16 patients aged 70–82 who wore the Corsano CardioWatch 287-2 before and after cancer surgery....
DETECT-1C: CardioWatch detects non-induced cardiac arrest with 100% sensitivity

DETECT-1C: CardioWatch detects non-induced cardiac arrest with 100% sensitivity

by Matthias Burel | Dec 18, 2021 | Publications

DETECT-1C: CardioWatch detects non-induced cardiac arrest with 100% sensitivity A prospective clinical validation study published in The Lancet Regional Health – Europe evaluated automated cardiac arrest detection using photoplethysmography signals from the Corsano...
Independent hypoxia study confirms CardioWatch 287-2 SpO₂ and pulse rate accuracy across skin tones

Independent hypoxia study confirms CardioWatch 287-2 SpO₂ and pulse rate accuracy across skin tones

by Matthias Burel | Dec 17, 2021 | Publications

Independent hypoxia study confirms CardioWatch 287-2 SpO₂ and pulse rate accuracy across skin tones Medtronic, distribution partner of Corsano Health, has completed a controlled hypoxia study evaluating the accuracy of blood oxygen saturation (SpO₂) and pulse rate...
Next Entries »

News

  • Corsano Health Wins Call Heart Foundation
  • Cardiac Surveillance in the Digital Age
  • Innovative Horizons in Hypertension Monitoring: Corsano’s CardioWatch 287-2 System
  • Corsano CardioWatch Impact Framework
  • Certified Software

Continuous Cardiac Monitoring
Anytime, Anywhere

Research

Patient Care

System

Resources

Company

Contact Us

Terms

Privacy

Security

GDPR

DPO

  • LinkedIn
  • Youtube
© 2025 Corsano Health - All rights reserved